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Abstract
Background: Chronic fatigue syndrome (CFS) is defined by debilitating fatigue that is exacerbated
by physical or mental exertion. To search for markers of CFS-associated post-exertional fatigue,
we measured peripheral blood gene expression profiles of women with CFS and matched controls
before and after exercise challenge.
Results: Women with CFS and healthy, age-matched, sedentary controls were exercised on a
stationary bicycle at 70% of their predicted maximum workload. Blood was obtained before and
after the challenge, total RNA was extracted from mononuclear cells, and signal intensity of the
labeled cDNA hybridized to a 3800-gene oligonucleotide microarray was measured. We identified
differences in gene expression among and between subject groups before and after exercise
challenge and evaluated differences in terms of Gene Ontology categories.
Exercise-responsive genes differed between CFS patients and controls. These were in genes
classified in chromatin and nucleosome assembly, cytoplasmic vesicles, membrane transport, and G
protein-coupled receptor ontologies. Differences in ion transport and ion channel activity were
evident at baseline and were exaggerated after exercise, as evidenced by greater numbers of
differentially expressed genes in these molecular functions.
Conclusion: These results highlight the potential use of an exercise challenge combined with
microarray gene expression analysis in identifying gene ontologies associated with CFS.
Background
In a state of health, physical exercise has a quantifiable
effect on neuroendocrine, autonomic, and immune sys-
tems influencing metabolic and immune responses. How-
ever, in the initial phase of acute illness, there is an
avoidance of physical stressors so energy can be dedicated
to healing and a return to homeostasis. While physiologic
disturbance in acute illness is transient, chronic illnesses,
such as chronic fatigue syndrome (CFS), have prolonged
disturbances that have a debilitating effect both physio-
logically and psychologically. Consequently, activities
that are physiologic stressors, such as physical exercise,
exacerbate the symptoms that define CFS.
CFS is a complex, multifactorial illness whose etiology
and pathophysiology remain unclear [1]. CFS is defined
by a characteristic symptom complex in the absence of
other medical or psychiatric conditions with similar clini-
cal characteristics [2,3]. Subtle differences in hypotha-
lamic-pituitary-adrenal axis function [4], immune system
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function [5], and psychological profiles [6] between CFS
patients and controls have been reported; however, no
consistent distinguishing difference or frank abnormality
has been confirmed [7,8], and it remains unclear whether
CFS represents a unique disease or a common illness
response to a variety of insults.
Perhaps the greatest methodological problem with study-
ing CFS is that many individuals identified in population
studies have been sick for at least 5 years [9]. During this
time, the illness waxes and wanes, making it difficult to
identify biomarkers or define pathogenesis. Physical,
mental, and emotional stress exacerbate CFS and result in
case-defining post-exertional fatigue [2] with measurable
physiologic differences [10]. Therefore, exercise challenge
of people with CFS is an effective method for calibrating
CFS subjects and thus increasing the likelihood of uni-
formly identifying biomarkers and/or physiologic
abnormalities.
We used gene expression profiling of peripheral blood to
evaluate differences between CFS subjects and sedentary
healthy controls both before and following an exercise
challenge. Overall, we found the gene expression profiles
to be quite similar, and of importance, most differences
were present prior to exercise challenge. These differences
were in G protein-coupled receptor and ion transport and
ion channel activity ontologies. The latter was exaggerated
after exercise as evidenced by differential expression of a
greater number of genes involved in these molecular func-
tions. Differences were also evident in exercise response,
including chromatin and nucleosome assembly, cytoplas-
mic vesicles, membrane transport and G-protein coupled
receptor ontologies. These differences may help explain
the symptoms of CFS.
Results
Exercise response genes were evaluated using a random
variance t test in a paired, class comparison analysis of
control subjects before and after exercise, and 21 genes
were identified as being differentially expressed (Table 2).
The probability of identifying these 21 genes by chance if
there are no real differences between the classes was 0.056
as determined by the multivariate permutation test.
Among the 21 genes, 16 could be categorized in the Gene
Ontology (GO) of biological process and 15 in molecular
function (results not shown). The most significant catego-
ries or "themes" of these exercise-responsive genes as
assessed by an EASE score of <0.10, pertained to the bio-
logical process of transport (both vesicle-mediated and
protein transport). 5 of the 21 genes were involved in this
process.
Since these 21 genes reflect a healthy subject's peripheral
blood gene expression response to exercise challenge, we
reasoned that the expression of these would be altered in
CFS subjects. To have a visual representation of these dif-
ferences, the gene list from Table 2 (differentially
Table 2: List of genes differentially expressed in exercised control subjects. The parametric p-value is a measure of the significance of 
the random variance t-statistic test used to identify differentially expressed genes in the class comparisons.
GenBank ID Description Parametric p-value
NM_003431 Zinc finger protein 124 (HZF-16) 0.0001
NM_003466 Paired box gene 8 0.0001
NM_003477 Pyruvate dehydrogenase complex, lipoyl-containing component X; E3-binding protein 0.0002
NM_003591 Cullin 2 0.0003
NM_003985 Tyrosine kinase, non-receptor, 1 0.0004
NM_003490 Synapsin III 0.0004
NM_003764 Syntaxin 11 0.0004
NM_003494 Dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive) 0.0006
NM_003715 Vesicle docking protein p115 0.0006
NM_003692 Transmembrane protein with EGF-like and two follistatin-like domains 1 0.0006
NM_003853 Interleukin 18 receptor accessory protein 0.0006
NM_003716 Ca2+-dependent activator protein for secretion 0.0006
NM_003558 Phosphatidylinositol-4-phosphate 5-kinase, I beta 0.0008
NM_003854 Interleukin 1 receptor-like 2 0.0009
NM_003543 H4 histone family, member H 0.0010
NM_003488 A kinase (PRKA) anchor protein 1 0.0013
NM_003487 TATA box binding protein (TBP)-associated factor, RNA polymerase II, N, 68 kD 0.0014
NM_003528 H2B histone family, member Q 0.0019
NM_003693 Acetyl LDL receptor; scavenger receptor expressed by endothelial cells 0.0021
NM_003473 Signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 0.0029
NM_004653 SMC (mouse) homolog, Y chromosome 0.0035BMC Physiology 2005, 5:5 http://www.biomedcentral.com/1472-6793/5/5
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expressed genes in control subjects, compared before and
after exercise challenge) was used in a two-way hierarchi-
cal cluster analysis (Figure 1). The response of 10 of the 21
genes was quite similar in terms of magnitude and direc-
tion for both CFS and control subjects (Figure 1, marked
in blue). For the other 11 genes, the magnitude of the
exercise change was considerably smaller in CFS subjects
(Figure 1, subject clusters 2 and 4) than in control subjects
(clusters 1 and 3). With regard to the GO categories of
these 21 genes, 10 genes were associated with binding and
8 with metabolism, all of which were equally distributed
between the two response types (denoted by # and   in
Hierarchical clustering of exercise responsive genes in control subjects Figure 1
Hierarchical clustering of exercise responsive genes in control subjects. The 21 differentially expressed genes identi-
fied by a class comparison test of control subjects (before and after exercise challenge (Table 2)) were clustered using a two-
way hierarchical algorithm. In the matrix each row represents the hybridization results for a single gene, and each column rep-
resents a subject. Transcript levels are depicted as above (red) or below (green) the mean. The dendograms illustrates aver-
age-linkage hierarchical clustering of subjects (top) and genes (left). Refseq IDs for each gene is given on the right of the matrix. 
Those with similar exercise responses in both CFS and control subjects are at the top of the matrix, and the remainder of 
genes (highlighted in blue) show a diminished exercise response in CFS cases. Refseq IDs highlighted in yellow classify to the 
GO categories of protein or vesicle-mediated transport (Biological Process). Refseq IDs followed by:   are classified to the 
GO category of binding (Molecular Function); and/or # are classified in the GO category of metabolism (Biological Process). 
The subjects group into 4 clusters which approximate to: 1) Control subjects before exercise (Con0); 2) CFS cases before 
exercise (CFS0); 3) Control subjects after exercise (Con24); and 4) CFS cases after exercise (CFS24).

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Figure 1). However, 5 genes classified in vesicle-mediated
and protein-transport ontologies differed between CFS
and control subjects (Figure 1, highlighted in yellow).
No differentially expressed genes were identified by class
comparison analysis (at a significance level of p > 0.005)
for CFS subjects before and after exercise, for CFS subjects
before exercise compared with controls before exercise, or
for CFS subjects after exercise compared with controls
after exercise.
Because differentially expressed genes were identified by
class comparison prior to the exercise challenge, we rea-
soned that a comparison of gene expression in CFS and
control subjects, using genes categorized by ontology,
would more efficiently reveal perturbed physiological
pathways. Figures 2 and 3 show the results of these analy-
ses. GO terms with defined parent-child relationships are
grouped together in the figures and are color-matched.
Only two exercise-responsive GO categories [phospholi-
pid binding (orange) and chromatin architecture (pale
green)] were common to controls and CFS subjects (Fig-
ure 2a and 2b). However, for the chromatin architecture
category, the CFS comparison highlighted 7 overlapping
ontologies (containing 59 unique genes), compared with
1 ontology of 33 genes in the control comparison. The 33
genes overlap with the 59 identified in the CFS compari-
son. The phospholipids-binding ontologies were identical
in gene composition. Exercise-related changes that were
identified as significant only in control subjects were asso-
ciated with genes involved with vesicle (yellow, Figure
2a), dehydrogenase (grey, Figure 2a), ATPase (pink, Figure
2a), and transporter (blue, Figure 2a), activities. Exercise-
related changes that were seen only in CFS subjects were
related to G-protein-coupled receptor signaling (purple,
Figure 2b).
Gene ontology comparison was also used to evaluate dif-
ferences between control and CFS subjects before (i.e.
baseline, Figure 3a) and after (Figure 3b) exercise. Base-
line differences between CFS subjects and controls that
continued after exercise involved GO terms relating to ion
transport (blue, Figure 3a). After exercise, these differ-
ences appear to be amplified, as evidenced by increased
numbers of genes present in these GO categories and also
by inclusion of more GO terms pertaining to ATPase
transmembrane movement of ions (pink, Figure 3b). G-
protein-coupled receptor binding (purple, Figure 3a), part
Significant gene ontology categories defining exercise-related changes in control (a) and CFS subjects (b) Figure 2
Significant gene ontology categories defining exercise-related changes in control (a) and CFS subjects (b). The 
three organizing principles of GO (represented as grey shaded boxes) are molecular function, biological process, and cellular 
component. Related ontologies and/or subgroups of the ontologies are denoted by similarly colored squares in all tables. 
Ontologies presented in these figures were significant at a p-value <0.005 by one or both of the LS and KS permutation tests.BMC Physiology 2005, 5:5 http://www.biomedcentral.com/1472-6793/5/5
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of the broad functional category of signal transduction,
differed between CFS subjects and controls prior to exer-
cise. This baseline difference between controls and CFS
subjects was not significant after exercise. Interestingly,
complement activation (dark green, Figure 3b) was one of
the exercise-induced differences between subjects and
controls that was present only after challenge. Genes in
most of the ontologies identified as different between CFS
and control subjects had lower expression levels in CFS
subjects.
Discussion
Gene expression profiling affords a unique opportunity to
characterize CFS at a systems biology level. Changes in
gene expression underlie many biologic processes and
may provide insight into disease-specific gene expression
and the response of genes to environmental stimuli. In a
proof-of-concept study, we found that CFS patients had
different blood mononuclear cell gene expression pat-
terns than non-fatigued controls [11] and that CFS is a
heterogeneous illness as evidenced by different gene
expression profiles for patients reporting gradual onset of
their illness compared with those reporting sudden onset
of illness [12]. In addition, differential display polymerase
chain reaction on a small number of CFS and control sub-
jects identified candidate biomarkers in the peripheral
blood [13,14].
CFS is defined by a post-exertional fatigue that does not
subside 24 hours following physical stress. In contrast,
exercise in healthy, untrained people induces changes in
cellular homeostasis in 1 to 4 hours and a return to basal
levels within 24 hours, as measured in muscle [15]. Anal-
ysis of peripheral blood gene expression in the healthy
control subjects confirmed this observation since the
majority of gene expression levels were the same before
and 24 hours following exercise challenge. This implied
that expression either returned to basal levels or was
unchanged as a result of the exercise challenge. And
indeed, many of the 21 exercise-induced, differentially
expressed genes in control subjects were characterized by
GOs that reflect a diverse set of molecular functions nec-
essary for cell function and viability. (These ontologies
overlapped with those identified in the GO comparison
analysis given in Figure 2a). Figure 1 clearly illustrates the
reciprocal pattern of gene expression in the 21 genes for
Gene Ontology categories identified as significantly different between controls and CFS cases at baseline (pre-exercise) (a) and  post-exercise (b) Figure 3
Gene Ontology categories identified as significantly different between controls and CFS cases at baseline (pre-
exercise) (a) and post-exercise (b). The three organizing principles of GO (represented by grey shaded squares) are 
molecular function, biological process, and cellular component. Related ontologies and/or subgroups of the ontologies are 
denoted by similarly colored squares in all tables. Ontologies presented in these figures were significant at a p-value <0.005 by 
one or both of the LS and KS permutation tests.BMC Physiology 2005, 5:5 http://www.biomedcentral.com/1472-6793/5/5
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most of the control subjects. In contrast, 11 of the genes
were unchanged in CFS subjects before and after exercise;
with 5 being classified in a transport-related ontology.
Because this difference in gene expression is so dramatic,
it implicates a fundamental perturbation in the biochem-
ical activity of lymphocyte and monocyte peripheral
blood fractions from CFS subjects compared with control
subjects that does not affect classical immunologic mark-
ers (i.e, CD45) that have been shown to be unaffected in
CFS patients [16,17]. Rather, low expression of these
genes may have subtle effects on immune function.
Immune dysfunction has been inconsistently implicated
in CFS pathogenesis [18].
Class comparison was used to identify these 21 differen-
tially expressed genes, which indicated the possible distur-
bance of biologic pathways (Figure 1). To explore this
possibility, we used the GO comparison that is based on
the knowledge that gene expression levels are dependent
variables in biological processes, cellular components,
and molecular functions. In this way, multiple genes in
the same category reinforce each other and enhance the
power for identifying the significance of the category. The
GO categories considered significantly different (p <
0.005) when comparing CFS subjects with controls after
exercise challenge were those pertaining to ion transporter
activity (a total of 87 genes applied to this category in the
comparison of CFS and controls after exercise) and
ATPase activity coupled to transmembrane movement (42
genes). When the CFS and control classes are compared
prior to exercise, ion transport activity and voltage-gated,
ion channel activity are identified (38 and 44 genes within
the GO categories, respectively).
It is evident that ion transport and ion channel activity
segregate cases from controls and that exercise seems to
intensify these differences. Several other conditions have
been reported in which fluctuating fatigue occurs that are
known to be caused by abnormal ion channels. These
conditions include genetically determined channelopa-
thies and acquired conditions such as neuromyotonia,
myasthenic syndromes, multiple sclerosis, and polyneu-
ropathies [19,20]. There are other transmembrane func-
tions associated with differences between controls and
CFS patients, including signal transducer activity through
receptor binding/activity (Figure 3a). Signal transduction
of transmembrane receptors occurs by a number of mech-
anisms, including structural changes, ion channels, and
changes of transmembrane potentials. The G-protein-cou-
pled receptors play an important role in the membrane
trafficking machinery [21]. The most obvious exercise-
induced changes in CFS cases pertain to gene regulation at
the point of chromatin structure; whether these changes
reflect the differences seen in the mRNA transcripts relat-
ing to membrane trafficking differences between cases
and controls has not yet been determined.
One interesting correlate of this study was the finding that
the complement pathway showed significant differences
between CFS and control subjects after exercise. This has
been reported previously in the analysis of these same
exercise challenge-derived specimens. Sorensen et al. [22]
measured levels of complement split products in the sera
of these subjects and found differences between CFS and
control subjects in C4a after exercise challenge. Comple-
ment activation was identified as an ontology that was sig-
nificantly different between CFS and control subjects after
exercise. The correlates on the data are interesting as their
study measured protein levels (i.e., gene product levels)
and this study measured the transcript levels.
The class comparison analysis performed in this study
accounted for multiple testing and the over fitting prob-
lems of microarray data analysis. The lack of statistical sig-
nificance in the 3 other class comparison analyses
performed (CFS cases compared before and after exercise,
comparison of cases to controls at baseline, and the com-
parison of cases to controls 24 hours after exercise) reflects
low experimental sensitivity, most likely due to a small
number of subjects, rather than an absence of biological
effect. This is accounted for in the gene ontology compar-
ison tool where classes are compared by GO category
rather than with regard to individual genes.
The next line of research will detail larger numbers of sub-
jects in the expression arrays. The emphasis in such stud-
ies will be on developing a gene expression-based
multivariate function, or predictor, that accurately
predicts the class membership of a new sample on the
basis of the expression levels of key genes. Class discovery
tools will also be applied to CFS subjects' expression pro-
files in an attempt to further describe discrete subsets of
this disease on the basis of gene expression as we have
done for gradual and sudden onset of illness [12]. How-
ever, the methods used in this study will be applied to
these data sets too, as these analytical tools will prove to
be very helpful in defining the pathophysiology of CFS. It
is hoped that this broader, more fully encompassing
approach to CFS research will open many doors to the
understanding of this syndrome and perhaps of fatigue
and un-wellness in general.
Methods
Study subjects
This study adhered to human experimentation guidelines
of the U.S. Department of Health and Human Services
and the Helsinki Declaration. All participants were volun-
teers who gave informed consent. Study parameters have
been described [22]. In brief, women who attended a CFSBMC Physiology 2005, 5:5 http://www.biomedcentral.com/1472-6793/5/5
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outpatient fatigue clinic volunteered for the study. All of
these patients met the current working definition for CFS
[2] that includes the following criteria: fatigue lasting
longer than 6 months or more, no other illness that could
explain the fatigue, 4–8 concurrent symptoms, fatigue
that is not relieved by rest, and fatigue that interferes with
occupational, educational and social or personal
activities.
Healthy controls were recruited through advertisements.
They were similar in age, sex, and activity level (sedentary
to moderately active) to the CFS patients. All women,
were scheduled for exercise challenge 5 to 10 days after the
first day of their menstrual cycle. All subjects were asked
not to use inhaled or systemic corticosteroids, anti-hista-
mines, or anti-inflammatory medication for 7 days prior
to the exercise challenge. Subjects performed a submaxi-
mal (70% predicted maximum work load), steady-state
exercise for 20 minutes on a stationary bicycle ergometer.
All subjects met these challenge criteria. Blood samples
were obtained immediately before and 24 hours follow-
ing exercise. The selection of subjects for inclusion into
the gene expression pilot study, focused on those without
allergies, to whom an exercise challenge was given: 5
women with CFS and 5 female controls.
RNA isolation
Immediately following blood collection, peripheral
blood mononuclear cells were isolated, using Ficoll gradi-
ents and stored in RNAqueous™ lysis buffer (Ambion Inc.,
Austin, TX) at -70°C. Total RNA was extracted using the
RNAqueous™ kit (Ambion), with quality and quantity
assessed by agarose gel electrophoresis as described previ-
ously [23].
Preparation and hybridization of labeled cDNA
Biotinylated cDNA synthesis from 1 µg of total RNA,
microarray hybridization, and detection were performed
as previously described [23]. Atlas™ Human 3.8I oligonu-
cleotide glass microarrays (Clontech Laboratories, Palo
Alto, CA) were used. The slides were archived and images
captured using the GSD-501™ scanner (Invitrogen Life
Technologies, Carlsbad, CA).
Data analysis
Preprocessing data
The scanned TIFF images were processed using ArrayVi-
sion™ (Imaging Research Inc., Ontario, Canada) as previ-
ously described [23]. A median background value was
calculated around each of the 3757 features and sub-
tracted from the mean feature signal to give the net signal
for the respective gene. Values were log2-transformed, and
a global normalization was used to median center the log
intensity values. Genes whose expression differed by at
least 1.5 fold from the median in at least 20% of arrays
were retained (3699 genes), thus excluding genes showing
minimal variation across the set of arrays. If an expression
value was missing or filtered out in more than 50% of the
arrays, that feature was not included, leaving a total of
3682 genes for analysis.
Analysis
We used several analytical approaches to look for differen-
tial expression among four predefined classes: control
subjects before exercise, control subjects after exercise,
CFS subjects before exercise, and CFS subjects after exer-
cise. Comparisons included paired analyses of controls
before versus after exercise and CFS cases before versus
after exercise. In addition, we examined pre-exercise
(baseline) controls versus pre-exercise CFS subjects and
post-exercise controls versus post-exercise CFS subjects.
Analytical approach 1
The more commonly used approach to microarray gene
expression analysis is to establish if gene expression pro-
files differ between subjects in predetermined classes and
to identify the genes responsible for the differences. The
Class Comparison analysis method in BRB ArrayTools
[24] uses this approach, applying a random variance t-test
to the data. This is an improvement over the standard t-
test as it permits sharing information among genes about
within-class variation without assuming that all genes
have the same variance [25]. It is an advisable modifica-
tion when the numbers of samples per class are small.
Genes were considered statistically significant if the para-
metric p-value was less than 0.005. Next a global, multi-
variate permutation test was performed to determine
whether the expression profiles differed between the
classes by permuting the array classification. We used this
test to provide a median false discovery rate of 10%.
The EASE software package [26] was then used to evaluate
the biologic significance of the ontology of genes identi-
fied as differentially expressed by class comparison. EASE
performs a statistical analysis of gene categories in a gene
list relative to all genes on the array and calculates a con-
servative variant of the standard Fisher exact probability
called the EASE score. The most significant categories as
assessed by EASE score are deemed "themes" of the gene
list. These themes correspond to the systematic and stand-
ardized nomenclature developed by the GO (Gene Ontol-
ogy) Consortium [27]. The three organizing principles of
GO are molecular function, biological process and cellu-
lar component, and presently 22,665 human gene prod-
ucts have been annotated. Associating genes with related
GO terms assists in the interpretation of expression pat-
terns. A GO category includes genes described by that
term and those included in any subset (or children) of
that GO term. A gene may be categorized in more than
one ontology category.BMC Physiology 2005, 5:5 http://www.biomedcentral.com/1472-6793/5/5
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To demonstrate the distinct gene clusters, we performed a
two-way hierarchical cluster analysis on the genes identi-
fied by this analytical approach, using the algorithm
described by Eisen et al. [28].
Analytical approach 2
We used the Gene Ontology comparison module of BRB
Array tools [24] as a second analytical approach. In this
method, the genes are assigned GO terms prior to analy-
sis. For each GO term the total number of genes on the
array belonging to that category was determined. A ran-
dom variance t-test or F-test [25] was used to determine
the p-value for differences between the predefined classes
for each gene in the GO term. Two statistics are computed
to summarize the p-values for all genes in the GO term:
the Fisher statistic and the Kolmogorov-Smirnov statistic
[24]. These p-values provide a list of GO categories that
have more genes differentially expressed among the
classes than expected by chance. We considered a GO cat-
egory differentially regulated if either significance level
was less than 0.005. All GO categories with between 5 and
100 genes represented on the array were considered.
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